Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.

Pascal O Berberat; Zilvinas Dambrauskas; Antanas Gulbinas; Thomas Giese; Nathalia Giese; Beat Künzli; Frank Autschbach; Stefen Meuer; Markus W Büchler; Helmut Friess

doi:10.1158/1078-0432.CCR-04-2159

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.

Identifier:nobleid.org/w1/20260515/3BCDAEE5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3BCDAEE5.svg?ark=w1%2F20260515%2F3BCDAEE5)](https://nobleid.org/work/w1/20260515/3BCDAEE5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.

Identifier:nobleid.org/w1/20260515/3BCDAEE5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3BCDAEE5.svg?ark=w1%2F20260515%2F3BCDAEE5)](https://nobleid.org/work/w1/20260515/3BCDAEE5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work